Praxis Precision Medicines, Inc.
PRAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689548
No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Praxis Precision Medicines, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 95 | 108 | +13 |
| Shares | 43.1M | 42.1M | −974.0K (−2.3%) |
| Value | $105.5M | $95.7M | −$9.87M (−9.4%) |
New holders (26)
Institutions that held Praxis Precision Medicines, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (13)
Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Woodline Partners LP | 308,746 | $756.0K |
| Rafferty Asset Management, LLC | 229,840 | $563.0K |
| UBS Group AG | 156,707 | $384.0K |
| Endurant Capital Management LP | 79,097 | $194.0K |
| PEAK6 Investments LLC | 74,468 | $85.6K |
| E Fund Management Co., Ltd. | 26,064 | $64.0K |
| Quantbot Technologies LP | 21,050 | $51.0K |
| Captrust Financial Advisors | 1,345 | $3.00K |
| US Bancorp | 205 | $1.00K |
| Nisa Investment Advisors, LLC | 550 | $1.00K |
| Signaturefd, LLC | 207 | $1.00K |
| Quadrant Capital Group LLC | 408 | $1.00K |
| Lindbrook Capital, LLC | 115 | $0 |